Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas M Wheeler

Showing results (41-50 of 143) with videos related to

Pageof 15
Sort By:
Urology|May 9, 2003
Association of plasma urokinase-type plasminogen activator and its receptor with clinical outcome in patients undergoing radical cystectomy for transitional cell carcinoma of the bladderShahrokh F Shariat, Mara A Monoski, Ben Andrews, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 7, 2009
Prognostic value of Akt-1 in human prostate cancer: a computerized quantitative assessment with quantum dot technologyRile Li, Hong Dai, Thomas M Wheeler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2004
Association of preoperative plasma levels of vascular endothelial growth factor and soluble vascular cell adhesion molecule-1 with lymph node status and biochemical progression after radical prostatectomyShahrokh F Shariat, Veronica A Anwuri, Dolores J Lamb, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2004
Association of pre- and postoperative plasma levels of transforming growth factor beta(1) and interleukin 6 and its soluble receptor with prostate cancer progressionShahrokh F Shariat, Michael W Kattan, Erica Traxel, et al.
The Journal of Urology|October 24, 2002
Bladder neck involvement in pathological stage pT4 radical prostatectomy specimens is not an independent prognostic factorOfer Yossepowitch, Kanishka Sircar, Peter T Scardino, et al.
Cancer Research|October 3, 2003
Early postoperative peripheral blood reverse transcription PCR assay for prostate-specific antigen is associated with prostate cancer progression in patients undergoing radical prostatectomyShahrokh F Shariat, Michael W Kattan, Weitao Song, et al.
Human Pathology|February 29, 2008
Malignant advanced granulosa cell tumor of the adult testis: case report and review of the literatureKai H Hammerich, Stephanie Hille, Gustavo E Ayala, et al.
The American Journal of Surgical Pathology|April 26, 2012
Do adenocarcinomas of the prostate with Gleason score (GS) ≤6 have the potential to metastasize to lymph nodes?Hillary M Ross, Oleksandr N Kryvenko, Janet E Cowan, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 20, 2005
A cancer DNA phenotype in healthy prostates, conserved in tumors and adjacent normal cells, implies a relationship to carcinogenesisDonald C Malins, Naomi K Gilman, Virginia M Green, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 19, 2003
Cancer-related changes in prostate DNA as men age and early identification of metastasis in primary prostate tumorsDonald C Malins, Paul M Johnson, Edward A Barker, et al.
Pageof 15

Showing results (41-50 of 143) with videos related to

Sort By:
Pageof 15
Urology|May 9, 2003
Association of plasma urokinase-type plasminogen activator and its receptor with clinical outcome in patients undergoing radical cystectomy for transitional cell carcinoma of the bladderShahrokh F Shariat, Mara A Monoski, Ben Andrews, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 7, 2009
Prognostic value of Akt-1 in human prostate cancer: a computerized quantitative assessment with quantum dot technologyRile Li, Hong Dai, Thomas M Wheeler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2004
Association of preoperative plasma levels of vascular endothelial growth factor and soluble vascular cell adhesion molecule-1 with lymph node status and biochemical progression after radical prostatectomyShahrokh F Shariat, Veronica A Anwuri, Dolores J Lamb, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2004
Association of pre- and postoperative plasma levels of transforming growth factor beta(1) and interleukin 6 and its soluble receptor with prostate cancer progressionShahrokh F Shariat, Michael W Kattan, Erica Traxel, et al.
The Journal of Urology|October 24, 2002
Bladder neck involvement in pathological stage pT4 radical prostatectomy specimens is not an independent prognostic factorOfer Yossepowitch, Kanishka Sircar, Peter T Scardino, et al.
Cancer Research|October 3, 2003
Early postoperative peripheral blood reverse transcription PCR assay for prostate-specific antigen is associated with prostate cancer progression in patients undergoing radical prostatectomyShahrokh F Shariat, Michael W Kattan, Weitao Song, et al.
Human Pathology|February 29, 2008
Malignant advanced granulosa cell tumor of the adult testis: case report and review of the literatureKai H Hammerich, Stephanie Hille, Gustavo E Ayala, et al.
The American Journal of Surgical Pathology|April 26, 2012
Do adenocarcinomas of the prostate with Gleason score (GS) ≤6 have the potential to metastasize to lymph nodes?Hillary M Ross, Oleksandr N Kryvenko, Janet E Cowan, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 20, 2005
A cancer DNA phenotype in healthy prostates, conserved in tumors and adjacent normal cells, implies a relationship to carcinogenesisDonald C Malins, Naomi K Gilman, Virginia M Green, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 19, 2003
Cancer-related changes in prostate DNA as men age and early identification of metastasis in primary prostate tumorsDonald C Malins, Paul M Johnson, Edward A Barker, et al.
Pageof 15